Dr. Peter Rogan will be presenting a paper at the TCGA symposium at the Natcher Conference Center on the NIH Campus, Bethesda, MD on May 12-13, 2014. The title and authors are:
Non-coding mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer. Dorman, S.N.1, Viner, C.2, Rogan, P.K1,2,3. 1Department of Biochemistry and 2Department of Computer Science, University of Western Ontario, London, ON, Canada, 3Cytognomix Inc., London, ON, Canada.
The paper describes the use of Cytognomix’s Shannon splicing mutation pipeline and Veridical software to discover novel aberrant pathways in metastatic breast cancer.
Details about the meeting can be found at the conference website (link).